Therefore, the enhanced NSCLC cell proliferation and growth in vitro and in vivo due to overexpression of SH2B1 could be explained, at least in part, by activation of Akt/mTOR pathway. The gene discussed is SH2B1; the disease is non-small cell lung carcinoma.